Additionally, study performed DEG analysis on 22 pre-treatment IBC samples who received NAT from GSE207248 dataset to identify genes differentially expressed between pCR and residual disease(RD) groups, and yielded 120 DEGs (Figure 1C). Here, BRD2 is linked to inflammatory breast carcinoma.